| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/08/2004 | EP1176971B1 Use of phyllanthus for treating chronic inflammatory and fibrotic processes |
| 09/08/2004 | EP1165505B1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 09/08/2004 | EP1156057B1 Malto-oligosaccharide derivatives and uses thereof |
| 09/08/2004 | EP1150746B1 The use of 4-h-1-benzopryan-4-one derivatives as inhibitors of smooth muscle cell proliferation |
| 09/08/2004 | EP1140933B1 Process for preparing n6-substituted deaza-adenosine derivatives |
| 09/08/2004 | EP1126870B1 Use of vegf-c or vegf-d gene or protein to prevent restenosis |
| 09/08/2004 | EP1122243B1 Novel imidazoles with anti-inflammatory activity |
| 09/08/2004 | EP1094712A4 Hypericin and hypericum extract: specific t-type calcium channel blocker, and their use as t-type calcium channel targeted therapeutics |
| 09/08/2004 | EP1089994B1 Novel form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same |
| 09/08/2004 | EP1084119B1 Aromatic amine derivatives as pharmaceutical agents |
| 09/08/2004 | EP1084114B1 Isothiazole derivatives useful as anticancer agents |
| 09/08/2004 | EP1079839B1 Therapeutic anti-cold agent containing isomalt as an active ingredient |
| 09/08/2004 | EP1075474B1 Process for making 1,3-disubstituted-4-oxocyclic ureas |
| 09/08/2004 | EP1064021B1 Use of cysteinprotease inhibitors for the manufacture of a medicament for prevention and treatment of brain tissue impairment due to hypertensive encephalopathy or encephalothlipsis. |
| 09/08/2004 | EP1047678B1 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
| 09/08/2004 | EP1039874B1 Compositions and methods for treatment of alopecia |
| 09/08/2004 | EP1014954B9 Transdermal therapeutic system |
| 09/08/2004 | EP1007523B9 Indole and 2,3-dihydroindole derivatives, their preparation and use |
| 09/08/2004 | EP1001802B1 A combined pharmaceutical preparation comprising parathyroid hormone and a bone resorption inhibitor |
| 09/08/2004 | EP0994876B1 Quaternary ammonium compounds as tachykinin antagonists |
| 09/08/2004 | EP0993456B1 2-substituted 4,5-diaryl imidazoles |
| 09/08/2004 | EP0991426B1 Method for transferring nucleic acid into the striated muscle |
| 09/08/2004 | EP0975370B9 Composition and method for enhancing transport across biological membranes |
| 09/08/2004 | EP0960127A4 Isolated dimeric fibroblast activation protein alpha, and uses thereof |
| 09/08/2004 | EP0950052B1 Method for preparing a tetrahydropyridin derivative |
| 09/08/2004 | EP0910331B1 Oxa diacids and related compounds for treating skin conditions |
| 09/08/2004 | EP0892852B1 Encapsulated cells expressing cytochrome p450 for prodrug activation |
| 09/08/2004 | EP0873131B1 Processes for preparation of rg3 and rg5 ginsenosides |
| 09/08/2004 | EP0835127B1 Composition containing a myelin-associated glycoprotein (mag) inhibitor which comprises an altered or mutated form of mag |
| 09/08/2004 | EP0824524B1 Alpha-substituted pyrimidine-thioalkyl and alkylether compounds as inhibitors of viral reverse transcriptase |
| 09/08/2004 | EP0813536B1 Process for the preparation of pharmaceutically acceptable salts of clavulanic acid |
| 09/08/2004 | EP0785782B1 Use of disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid-like activity |
| 09/08/2004 | EP0758232B1 Methods for modulating t cell responses by manipulating intracellular signal transduction |
| 09/08/2004 | EP0729455B1 Indole-derived azylpiperazines as ligands for 5ht1-like receptors 5ht1b and 5ht1d |
| 09/08/2004 | EP0723437B1 Multiple unit pharmaceutical preparation containing proton pump inhibitor |
| 09/08/2004 | EP0685486B1 Method of manufacturing lactulose anhydride |
| 09/08/2004 | EP0623126B1 Imidazole derivatives and their use as cytokine inhibitors |
| 09/08/2004 | CN2638761Y Esophagus medicine stent |
| 09/08/2004 | CN1527840A Use of CD 25 binding molecules in steroid-resistant patients |
| 09/08/2004 | CN1527838A Anti-inflammatory 17. beta-carbothioate ester derivatives of androstane with a cyclic ester group in position 17. alpha |
| 09/08/2004 | CN1527836A Antiviral agents for treatment of flaviviridae infections |
| 09/08/2004 | CN1527831A Antagonists of MCP-q function and method of use thereof |
| 09/08/2004 | CN1527830A Ether derivatives useful as inhibitors of PDE4 isozymes |
| 09/08/2004 | CN1527829A Pyrazole derivatives as HIV reverse transcriptase inhibitors |
| 09/08/2004 | CN1527828A 4-(penyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 09/08/2004 | CN1527827A Therapeutic heterocyclic compounds |
| 09/08/2004 | CN1527825A Method for the preparation of escitalopram |
| 09/08/2004 | CN1527824A Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derilatives as IP antagonists |
| 09/08/2004 | CN1527823A Deuterated 3-piperidinopropiophenone and medicaments containing said compounds |
| 09/08/2004 | CN1527822A Thiazole derivatives for treating PPAR related disorders |
| 09/08/2004 | CN1527820A 4-(phenyl-piperazinyl-methyl)benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestional disorders |
| 09/08/2004 | CN1527818A 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders |
| 09/08/2004 | CN1527816A New indole derivatives with 5-HT6 receptor affinity |
| 09/08/2004 | CN1527814A Nitric oxide synthase inhibitor phosphate salt |
| 09/08/2004 | CN1527813A ANtioxidant nitroxides and nitrones as therapeutic agents |
| 09/08/2004 | CN1527811A Process for the preparation of (R)-or (S)-aminocarnitine inner salt, the salts and derivatives thereof |
| 09/08/2004 | CN1527724A Liquid formulation comprising cetuximab and a fatty acid ester of polyoxyethylene sorbitan |
| 09/08/2004 | CN1527717A Remedies |
| 09/08/2004 | CN1527716A Anti-virus agent |
| 09/08/2004 | CN1527715A Metabolic controlled fermentation process for carbamoyl tobramycin production |
| 09/08/2004 | CN1527714A Pharmaceutical composition and method for treating hypogonadism |
| 09/08/2004 | CN1527713A Methods for treating delirium using glucocorticoid receptor-specific antagonists |
| 09/08/2004 | CN1527712A Active ingredient combination for medicamentous therapy of nicotine dependency |
| 09/08/2004 | CN1527711A Active substance combination for medicamentous therapy of habituation of or habitual material or narcotics |
| 09/08/2004 | CN1527710A Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands |
| 09/08/2004 | CN1527709A Therapeutic combinations for cardiovascular and inflammatory indications |
| 09/08/2004 | CN1527708A Medicinal composition for treating interstitial cystitis |
| 09/08/2004 | CN1527707A The use of substituted azetidinone compounds for the treatment of sitosterolemia |
| 09/08/2004 | CN1527706A Pharmaceutical compositions containing terbinafin and use thereof |
| 09/08/2004 | CN1527705A Pharma ceutical formulation containing and LTB4 antagonist |
| 09/08/2004 | CN1527704A Compositions and method of administering tubulin binding agents for the treatment of ocular diseases |
| 09/08/2004 | CN1527703A Pharmaceutical composition for preventing and treating cancer and treating an inflammation |
| 09/08/2004 | CN1527701A Tablets quickly disintegrated in oral cavity |
| 09/08/2004 | CN1527700A Compaction process for manufacture of sodium phenytoin dosage form |
| 09/08/2004 | CN1527670A Aimal growth regulating composition and its prepn and use |
| 09/08/2004 | CN1526818A Method of blocking expression of hepatitis B virus |
| 09/08/2004 | CN1526728A Human tumor generating and metastasis promoting acceptor molecule and its encoding gene and application |
| 09/08/2004 | CN1526727A Mouse tumor generating andmetastasis promoting acceptor and its encoding gene and application |
| 09/08/2004 | CN1526722A New taraxerol derivative and its prepn and use |
| 09/08/2004 | CN1526719A Deoxyoligonucleotide containing CpG single strand for strengthening immunological effect of Protein vaccine |
| 09/08/2004 | CN1526718A Antivira and antitumor deoxyoligonucleotide containing CpG single strand |
| 09/08/2004 | CN1526713A Combretastatin A-4 as phosphorylcholine precursor medicine and its synthesis and application |
| 09/08/2004 | CN1526448A Medicine and method for the treatment of anorectal disorders |
| 09/08/2004 | CN1526425A Acupoint injecting medicine liquid for treating femoral head necrosis |
| 09/08/2004 | CN1526422A Composition with functions of regulating immunity and resisting fatigue and its prepn, use and quality control method |
| 09/08/2004 | CN1526409A Medicated food for preventing and treating several kinds of diseases such as: alcoholism, fatty liver, diabetes and its making process |
| 09/08/2004 | CN1526408A Ribavirin gel as eye medicine and its production process |
| 09/08/2004 | CN1526407A Antitumor protopanoxadiol injection and its prepn process |
| 09/08/2004 | CN1526406A Prepn process of combined delayed releasing agent for preventing and treating animal's tinea pedis and mite disease |
| 09/08/2004 | CN1526405A Antitumor ginsenoside Rg3 injection and its prepn process |
| 09/08/2004 | CN1526404A Antitumor ginsenoside C-K injection and its prepn process |
| 09/08/2004 | CN1526403A Antitumor ginsenoside Rh2 injection and its prepn process |
| 09/08/2004 | CN1526402A Use of anthraglucorhein in preparing medicine for treating ischemic cerebral vascular diseases |
| 09/08/2004 | CN1526401A Medicine composition for treating coronary heart disease and its prepn process, use and guality control method |
| 09/08/2004 | CN1526400A Tubiflorous desert cistanche prepn containing phenethyl alcohol glycoside and its prepn process and use |
| 09/08/2004 | CN1526399A Diammonium glycyrrhizinate freeze drying powder for injection and its prepn |
| 09/08/2004 | CN1526398A Compound blood pressure reducing prepn containing angiotonin converzyme inhibitor, calcium ion agonist and Estazolam |
| 09/08/2004 | CN1526397A Combined antibiotic medicine for inhibiting beta-lactamase |
| 09/08/2004 | CN1526396A New prepn form of cefmenoxime hydrochloride for injection |
| 09/08/2004 | CN1526395A Tegafur-sodium chloride injection and its prepn |